Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
clotrimazole
Arpimed LLC
G01AF02
clotrimazole
20mg/g
cream vaginal
50g aluminium tube and (3) applicator
Prescription
Registered
2018-07-11
SUMMARY OF PRODUCT CHARACTERISTICS (SPC) CLOTRIMAZOLE 2% VAGINAL CREAM 1. NAME OF THE MEDICINAL PRODUCT - Clotrimazole NON-PROPRIETARY NAME - Clotrimazole 2. QUANTITATIVE AND QUALITATIVE COMPOSITION Each gram of Clotrimazole, vaginal cream 2%, contains: ACTIVE INGREDIENT: Clotrimazole - 20 mg; For a full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM A homogeneous cream with smooth white colour, odourless. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clotrimazole is indicated for the 3-day treatment of vaginal candidiasis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended daily dose is one full applicator intravaginally for three consecutive days, preferably at bedtime. Sufficient cream is provided for 3 intravaginal applications. _Dosing Considerations _ Vaginal Candidiasis may be accompanied by irritation in the vaginal area. Therefore, concomitant local treatment with Clotrimazole applied to the irritated vaginal area and as far as the anal region twice a day is advisable. Clotrimazole applied on the glans penis may prevent re- infection by the partner. N.B.: The cream should be inserted deep intravaginally by means of the applicator. The plunger should then be depressed slowly. 4.3 CONTRAINDICATIONS Patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container. 4.4 PRECAUTIONS FOR USE AND SPECIAL WARNINGS GENERAL Clotrimazole is not for ophthalmic use. Patients should seek medical advice if they have frequent vaginal infections or if their yeast infection returns in less than 2 months. Patients should seek medical advice if they suffer from diabetes mellitus, or have underlying immunodeficiency disease (such as HIV-AIDS). As with all topical agents, skin sensitization may result. Use of Clotrimazole topical preparations should be discontinued should such reactions occur, and appropriate therapy instituted. Treatment during the menstrual period should not be performed. The treatment should be finished before the onset of menstruati Read the complete document